MGP Ingredients vs Hawkins
CASK and HWKN side by side, both in wholesale trade-non-durable goods. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CASK and HWKN compare
Hawkins is the larger company, worth 8.5 times as much as MGP Ingredients ($3.2B against $375M).
Hawkins grew revenue faster over the last twelve months (9.0% versus −15.9% for MGP Ingredients).
Hawkins keeps more of each dollar of sales as profit, with a net margin of 7.5% compared with −51.4% at MGP Ingredients.
Both pay dividends: MGP Ingredients yields 2.7% and Hawkins 0.51%.
Hawkins scores higher on the StockData Score (14 against 5 for MGP Ingredients), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CASK | HWKN |
|---|---|---|
| Size and price | ||
| Market cap | $375M | $3.2B |
| Share price | $17.52 | $152.00 |
| Change, 1 year | −29.5% | 18.3% |
| Change, 5 years | −76.1% | 310% |
| Beta (5Y) | 0.68 | 0.71 |
| Employees | 617 | 1,200 |
| StockData Score | ||
| Total score | 5 | 14 (better) |
| Valuation score | 3 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 6 (better) |
| Health score | 1 | 3 (better) |
| Dividend score | 1 | 3 (better) |
| Valuation | ||
| P/E | – | 36.9× |
| P/S | 0.8× (better) | 2.8× |
| P/B | 0.6× (better) | 5.6× |
| EV/EBITDA | – | 18.7× |
| P/FCF | 712× | 34.3× (better) |
| PEG | – | 3.36 |
| FCF yield | 0.14% | 2.9% (better) |
| Fair value | $43.03 | $87.67 |
| Margin of safety | 59.3% (better) | −73.4% |
| Growth | ||
| Revenue growth (TTM) | −15.9% | 9.0% (better) |
| Revenue growth, 5Y average | 6.3% | 12.7% (better) |
| Net income growth (TTM) | – | 3.2% |
| EPS growth (TTM) | – | 3.5% |
| EPS growth, 5Y average | – | 15.2% |
| Profitability | ||
| Gross margin | 34.7% (better) | 22.4% |
| Operating margin | −57.2% | 11.1% (better) |
| Net margin | −51.4% | 7.5% (better) |
| FCF margin | 0.11% | 8.1% (better) |
| Return on equity | −34.5% | 16.0% (better) |
| Return on invested capital | −21.6% | 12.8% (better) |
| Financial health | ||
| Debt / equity | 0.57 | 0.41 (better) |
| Net debt / EBITDA | – | 1.22 |
| Current ratio | 6.91 (better) | 2.28 |
| Altman Z-score | 1.04 | 6.71 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Dividend yield | 2.7% (better) | 0.51% |
| Payout ratio | – | 18.7% |
| Years of dividend growth | 0 | 7 (better) |
| Dividend growth, 5Y average | 0.00% | 9.7% (better) |
| Buyback yield | 0.25% | 0.59% (better) |
| Shareholder yield | 3.0% (better) | 1.1% |
| Ownership | ||
| Held by institutions | 72.3% | 77.9% |
| Held by insiders | 75.3% | 4.2% |
| Insider net buying, 12 months | −$9.6M | $650K (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | – | 6.6% |
Go deeper
- CASK stock overview
- CASK income statement
- CASK valuation and score
- HWKN stock overview
- HWKN income statement
- HWKN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.